Receptor‐mediated drug delivery presents an opportunity to enhance therapeutic efficiency
by accumulating drug within the tissue of interest and reducing undesired, off‐target effects …

We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox)
nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES) …

Hepatocellular carcinoma is the second leading cause of cancer deaths worldwide. It is
characterized by unique features that can be utilized for selective and targeted therapy …

Hepatocyte-targeting and shell cross-linked nanoparticles with lactose moiety on the surface
and doxorubicin (DOX) in the core were prepared from lactose-PEG-DOX conjugate. The …

Receptor-mediated tumor targeting has received major attention in the field of cancer drug
delivery in the past few years. Receptors, as molecular target has opened new opportunities …

Hepatocellular carcinoma (HCC) is among the primary drivers of cancer‐related death
globally, owing to the ineffectiveness of treatments in intermediate and terminal stages—an …

Cytotoxic drugs, which are commonly used for the pharmacotherapy of many forms of
cancer, often cause substantial toxicity to the patient without being able to induce long …

A series of bifunctional compounds with galactosyl residues as targeting ligand for
asialoglycoprotein receptors on hepatocytes and various dendrimers as the DNA-binding …

Enhanced cancer treatment remains as one of the focused areas for researchers around the
world. Hence, the progress in this direction will be a challenge and an opportunity in, inter …